Drugs Glass Packaging Market Hits USD 4.99 by 2034

Drugs Glass Packaging Market Size, Trends, Segments, Regional Analysis (NA, EU, APAC, LA, MEA), Competitive Landscape, Value Chain and Trade Insights

The global drugs glass packaging market is expanding rapidly due to growing demand for injectable medicines, with injections representing over 55% of application-based demand in 2024. The market is on track to reach USD 8.17 billion by 2034, driven by higher healthcare spending and an increase in chronic diseases globally. APAC led the market in 2024 with the highest revenue share, while North America is projected to grow at over 6% CAGR during 2025–2034. On the trade front, China, India, and Germany remain top exporters of pharmaceutical glass, with China growing its export volume by over 8% year-on-year. The value chain reflects strong backward integration in raw glass production, with APAC controlling nearly half of the global melting capacity. Supplier networks expanded in 2023–2024 due to the surge in vaccine and biologics packaging demand.

Last Updated: 13 November 2025 Category: Healthcare Packaging Insight Code: 5357 Format: PDF / PPT / Excel

The drugs glass packaging market is expected to grow from USD 5.51 billion in 2025 to USD 8.17 billion by 2034, registering a CAGR of 5.05%. This report covers complete market size statistics, segmentation by type (cartridges, vials, ampoules) and application (injection, transfusion), along with deep regional analysis across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. It discusses leading companies such as SCHOTT AG, Gerresheimer, Nipro, SGD Pharma, Corning, PGP Glass, and others while presenting competitive benchmarking, manufacturing capabilities, value chain structure, global trade data, import–export flows, and supplier networks driving the industry.

Drugs Glass Packaging Market Revenue 2024 - 2034

The market is proliferating due to the increasing pharmaceutical industries due to continuous research and funding. These drugs need safe contamination-free packaging which can also enhance the shelf life of the products. This eco-friendly, safe and sustainable packaging demand in several industries significantly drives the drugs glass packaging market.

Key Takeaways

  • Asia Pacific led the drugs glass packaging market with the highest share in 2024.
  • By region, North America is expected to witness the highest CAGR during the forecast period.
  • By type, the cartridges segment held a dominant market share in 2024.
  • By application, the injection segment is anticipated to grow with the highest CAGR during the forecast period.

Market Overview

The drugs glass packaging market is an important industry in the healthcare packaging sector. This deals with sustainable packaging and transporting medicinal glass packaging to several areas. This market is generally driven by the rising trend of eco-friendly packaging and reliable glass packaging demand among consumers which should also be convenient. The drugs glass packaging industry manufactures different types of glass bottles with various requirements such as shapes, sizes, quality, locking systems, and many others.

This industry manufactures different quality glass with a variety of designs which create a difference from one brand to another. These packaging glasses are of different types according to their composition and medical demand. As there is a huge demand for eco-friendly drugs glass packaging the growth factor of this industry is exponential.

Drivers

Growing Demand for Injectable Medicines Products: Market’s Largest Driver

main developments in the drugs glass packaging market is the growing demand for medical products due to rising diseases globally. Drugs glass packaging has a longer shelf life that attracts consumers to use it for convenience storage. With the rise of chronic diseases resulting in the growth of drugs glass packaging is getting popular now with more chronic to various diseases at an early age. These are some of the most popularly prescribed drugs by healthcare experts due to the non-reactive properties of glass with chemicals globally, with a noteworthy upsurge in demand in developing markets such as India, Japan, Thailand, China, South Korea, and many others.

This rise in chronic diseases is causing a rising number of patients due to the changing lifestyle of youth and social norms with unhealthy habits resulting in using drugs glass packaging often. The development in the field of the healthcare sector led to rising demand for new medicines for various diseases which favour drugs glass packaging for their moisture-free packaging and capability to preserve the quality and worth of the medicine driving the demand in the industry.

Drugs glass packaging delivers high-quality barrier assets, shielding the product quality from outer impurities and conserving its quality which makes it easy to maintain brand status and customer fulfilment.

  • In October 2023, SCHOTT AG, announced the launch of FIOLAX® Pro glass tube. It is a new type I borosilicate glass, designed to meet three major trends in the industry: increasingly complex pharmaceuticals, sustainable products and circular economy, and digitalization.
  • The availability of customization options for drugs glass packaging for healthcare markets according to their requirement led to growth in the business of this drugs packaging market.
  • The capacity to withstand external conditions and the transportation of these glass bottles from one place to another in an organized manner led to the growth of the drugs glass packaging market. These glasses help to transport medicinal products without any contamination.
  • The growing demand for eco-friendly packaging raised the drugs glass packaging market. As it can be recycled and reused several times which makes it more preferrable by consumers.
  • Assurance proposes to improve the safety, effectiveness, and ecological sustainability of pharmacological product packaging, supporting global industry extension.

Market Opportunity

Growing Demand for Medicine Glass Bottles: To Open the Doors for Market

One of the important opportunities in the drugs glass packaging market is the rising patient belief in the medicine packaging industry. As customers become more perceptive and exploratory in their medical packaging options, there is a growing demand for exclusive and superior-quality glass packaging medicines. This factor is pushing the development of packaging and transportation businesses, which frequently prefer drugs glass packaging for the safety of the medicines and the capability to maintain the shelf-life of the medicinal products.

Moreover, the growing number of patients with several diseases such as heart attack, diabetes, cancer, and many other issues raise packaged medicine or vaccine delivery additional opportunities for modified and limited medicinal glass bottle packaging solutions. Another chance lies in the rising importance of sustainability and environment-friendly drugs glass packaging options. Patients are more ecologically conscious and are looking for products that line up with their ethics. Drugs glass packaging is highly recyclable and is well-placed to take advantage of this tendency.

There is a higher chance of leakage in such packaging which can cause damage to medicines, vaccines, and various healthcare products. Such issues hinder the growth of the drugs glass packaging market.

Regional Insights

Growing Funding from the Governments: Asia to Sustain as a Leader

Asia Pacific witnessed the largest revenue share for the year 2024 this growth is because of the growing investment by the government sector and awareness among people towards various diseases. This development is mainly driven by the growing number of patients with chronic diseases such as heart attack, diabetes, high blood pressure, stroke and various others in countries such as Japan, China, South Korea, Thailand, and India.

The growing demand for high-quality drug packaging influences the drugs glass packaging industry.  Moreover, favourable government guidelines and funds in the medicine industry provide additional support to market development. The Asia Pacific market delivers noteworthy opportunities for medical product glass packaging to tap into the increasing customer base and grow advanced packaging solutions personalized to the preferences of the region.

Some of the major market players contributing to the growth of the drugs glass packaging market are Ajanta Bottle Pvt. Ltd., PGP Glass, SCHOTT AG, SGD Pharma, Gerresheimer AG, NIPRO CORPORATION, AGI glaspac, Amazing Enterprises, and many others. These are well-known for producing drugs glass packaging solutions for the healthcare industry in India.

  • In September 2024, SGD Pharma, announced its first campaign using 20% post-consumer recycled (PCR) glass cullet packaging at Luxe Pack Monaco.

China Market Trends

China's drug glass packaging market is driven by the advanced manufacturing capabilities, export growth & global supply chain role in the country. China is becoming a major export hub for drug packaging materials. Competitive pricing, scaling capacity, and improving quality standards make Chinese firms attractive partners in global pharmaceutical supply chains. China is the second-largest pharmaceutical market in the world. As domestic and export-oriented drug production increases, the demand for high-quality drug packaging, including glass vials, ampoules, and syringes, rises. In China, heavy investments in automation and high-precision equipment for glass packaging production have fuel the growth of the drug glass packaging market.

Rising Demand for Contamination-free Packaging, To Promote North America’s Presence

North America is estimated to grow at the fastest rate over the forecast period. The drugs glass packaging market shows a changing demand for medicinal products across diverse regions, driven by several aspects such as growing diseases, changing lifestyles, consumption of fried oily food, excessive consumption of alcohol, and personalized medicinal product using trends. In countries such as the U.S. and Canada, the market is considered by a strong changing lifestyle which led to the demand for online medicines and a superior quality of packaging of drugs and vaccines. These countries have numerous major market players such as Gerresheimer AG, West Pharmaceutical Services Inc., Ardagh Group, Berry Global, Corning Incorporated, and many others which contribute significantly to the growth of this market.

  • In September 2024, Ardagh Glass Packaging, announced the launch of 500ml Celebration bottle on their BuyOurBottles website.

U.S. Market Trends

The U.S. drug glass packaging market is driven by several factors. U.S. supports the growth of the drug glass packaging market through a combination of regulatory standards, technological innovations, and a robust pharmaceutical industry. The U.S. Food and Drug Administration (FDA) enforces strict guidelines that promote the utilization of high-quality, safe, and effective packaging materials, driving demand for premium glass products like Type I borosilicate glass. Significantly investment in Research & Development, automation, and cleanroom manufacturing enhances production capabilities and innovation in packaging solutions. The strong presence of leading pharmaceutical companies and biotech firms further stimulates market growth, as injectables and biologics require advanced glass containers. Additionally, public and private funding for healthcare and life sciences supports expansion in drug manufacturing, indirectly fueling sustained demand for reliable, sterile, and durable glass packaging.

Segmental Insights

By type, the cartridges segment led the drugs glass packaging market in 2024. The cartridge glass bottle packaging is widely used in the healthcare sector as these are capable of intact the quality of the vaccines. Such cartridge bottles are considered to be appropriate for patients. 

By application, the injections segment led the drugs glass packaging market in 2024. These are highly preferred by healthcare experts for some chronic diseases to start the effect of the medicine quickly in the body and boost the demand in the drugs packaging market. Injection glass tubes help to maintain the quality of medicines which is preferred by brands as well as patients.

New Advancements in the Drug Glass Packaging Industry

  • In October 2024, Nipro PharmaPackaging, a leader in medical devices, glass tubing, and glass primary packaging, revealed the introduction of the D2F (Direct-To-Fill) glass vials. With the help of Stevanato Group’s cutting-edge EZ-fill technology, these vials provide a premium ready-to-use (RU) solution made to satisfy the exacting standards and growing demand of the pharmaceutical sector.
  • In January 2025, SGD Pharma, a leader in the pharmaceutical glass primary packaging solutions market worldwide, showcased its cutting-edge line of goods and services at Pharmapack at booths B55 and B59. Among these is its platform Sealian, an internal treatment that improves the functionality of molded glass vials. Pharmapack, the premier European pharmaceutical packaging trade event, will take place in Paris, France.

Recent Developments

  • In August 2024, Eli Lilly, announced the launch of a low-price weight loss drug without an injector pen. It is part of a new class of medications used to treat obesity and diabetes.
  • In November 2023, Becton Dickinson, announced the launch of a glass prefillable syringe (PFS). The syringe reduces the risk of line stoppage and improves the total cost of ownership, manufacturing capacity, and supply availability.

Drugs Glass Packaging Market Companies

Drugs Glass Packaging Market Companies

Drugs Glass Packaging Market Segments

By Type

  • Cartridges
  • Vials
  • Ampoules

By Application

  • Injection
  • Transfusion

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait

Tags

Share With : linkedin twitter facebook
  • Insight Code: 5357
  • No. of Pages: 150
  • Format: PDF/PPT/Excel
  • Last Updated: 13 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021–2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

Meet the Team

Yogesh Kulkarni is an experienced Research Analyst specializing in the packaging sector, with a strong foundation in statistical analysis and market intelligence. He currently contributes his expertise to Towards Packaging.

Learn more about Yogesh Kulkarni

Aditi Shivarkar, with 14+ years in packaging market research, specializes in food, beverage, and eco-friendly packaging. She ensures accurate, actionable insights, driving Towards Packaging 's excellence in industry trends and sustainability.

Learn more about Aditi Shivarkar

Related Insights

FAQ's

The drugs glass packaging market size reached US$ 4.99 billion in 2024 and is projected to hit around US$ 8.17 billion by 2034.

5.05% is the growth rate of the drugs glass packaging industry.

Asia Pacific region leads the global drugs glass packaging market.

SCHOTT AG, Gerresheimer AG, NIPRO Corporation, SGD Pharma, West Pharmaceutical Services Inc., PGP Glass, Ardagh Group, Corning Incorporated, Şişecam, Bormioli Pharma S.p.a., Stölzle-Oberglas GmbH, Ajanta Bottle Pvt. Ltd., Becton, Dickinson and Company, Amcor, Berry Global, and Borosil are the prominent players operating in the drugs glass packaging market.